Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Brain Behav Immun ; 49: 246-54, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26100488

ABSTRACT

All individuals experience stress and hormones (e.g., glucocorticoids/GCs) released during stressful events can affect the structure and function of neurons. These effects of stress are best characterized for brain neurons; however, the mechanisms controlling the expression and binding affinity of glucocorticoid receptors in the spinal cord are different than those in the brain. Accordingly, whether stress exerts unique effects on spinal cord neurons, especially in the context of pathology, is unknown. Using a controlled model of focal excitotoxic lower motor neuron injury in rats, we examined the effects of acute or chronic variable stress on spinal cord motor neuron survival and glial activation. New data indicate that stress exacerbates excitotoxic spinal cord motor neuron loss and associated activation of microglia. In contrast, hypertrophy and hyperplasia of astrocytes and NG2+ glia were unaffected or were modestly suppressed by stress. Although excitotoxic lesions cause significant motor neuron loss and stress exacerbates this pathology, overt functional impairment did not develop in the relevant forelimb up to one week post-lesion. These data indicate that stress is a disease-modifying factor capable of altering neuron and glial responses to pathological challenges in the spinal cord.


Subject(s)
Microglia/physiology , Motor Neurons/pathology , Spinal Cord Injuries/pathology , Spinal Cord Injuries/physiopathology , Stress, Psychological/pathology , Stress, Psychological/physiopathology , Animals , Cell Proliferation , Disease Models, Animal , Excitatory Amino Acid Agonists/pharmacology , Female , Glutamic Acid/pharmacology , Microglia/drug effects , Motor Neurons/drug effects , Rats , Rats, Sprague-Dawley , Restraint, Physical , Spinal Cord/drug effects , Spinal Cord/pathology , Spinal Cord/physiopathology
2.
J Neurosci ; 31(27): 9910-22, 2011 Jul 06.
Article in English | MEDLINE | ID: mdl-21734283

ABSTRACT

Macrophages exert divergent effects in the injured CNS, causing either neurotoxicity or regeneration. The mechanisms regulating these divergent functions are not understood but can be attributed to the recruitment of distinct macrophage subsets and the activation of specific intracellular signaling pathways. Here, we show that impaired signaling via the chemokine receptor CX3CR1 promotes recovery after traumatic spinal cord injury (SCI) in mice. Deficient CX3CR1 signaling in intraspinal microglia and monocyte-derived macrophages (MDMs) attenuates their ability to synthesize and release inflammatory cytokines and oxidative metabolites. Also, impaired CX3CR1 signaling abrogates the recruitment or maturation of MDMs with presumed neurotoxic effects after SCI. Indeed, in wild-type mice, Ly6C(lo)/iNOS(+)/MHCII(+)/CD11c(-) MDMs dominate the lesion site, whereas CCR2(+)/Ly6C(hi)/MHCII(-)/CD11c(+) monocytes predominate in the injured spinal cord of CX3CR1-deficient mice. Replacement of wild-type MDMs with those unable to signal via CX3CR1 resulted in anatomical and functional improvements after SCI. Thus, blockade of CX3CR1 signaling represents a selective anti-inflammatory therapy that is able to promote neuroprotection, in part by reducing inflammatory signaling in microglia and MDMs and recruitment of a novel monocyte subset.


Subject(s)
Antigens, Ly/metabolism , Macrophages/metabolism , Nitric Oxide Synthase Type II/metabolism , Receptors, Chemokine/deficiency , Recovery of Function/genetics , Signal Transduction/physiology , Spinal Cord Injuries/pathology , Spinal Cord Injuries/physiopathology , Analysis of Variance , Animals , CD11 Antigens/metabolism , CX3C Chemokine Receptor 1 , Cells, Cultured , Chemokine CXCL1/genetics , Chemokine CXCL1/metabolism , Disease Models, Animal , Flow Cytometry , Gene Expression Regulation/genetics , Green Fluorescent Proteins/genetics , Mice , Mice, Inbred C57BL , Mice, Transgenic , Motor Activity/genetics , Motor Activity/physiology , Myelin Basic Protein/metabolism , Nitric Oxide/metabolism , Signal Transduction/genetics , Spinal Cord Injuries/genetics
3.
Neural Plast ; 2012: 261345, 2012.
Article in English | MEDLINE | ID: mdl-22530155

ABSTRACT

The proinflammatory cytokine TNFα contributes to cell death in central nervous system (CNS) disorders by altering synaptic neurotransmission. TNFα contributes to excitotoxicity by increasing GluA2-lacking AMPA receptor (AMPAR) trafficking to the neuronal plasma membrane. In vitro, increased AMPAR on the neuronal surface after TNFα exposure is associated with a rapid internalization of GABA(A) receptors (GABA(A)Rs), suggesting complex timing and dose dependency of the CNS's response to TNFα. However, the effect of TNFα on GABA(A)R trafficking in vivo remains unclear. We assessed the effect of TNFα nanoinjection on rapid GABA(A)R changes in rats (N = 30) using subcellular fractionation, quantitative western blotting, and confocal microscopy. GABA(A)R protein levels in membrane fractions of TNFα and vehicle-treated subjects were not significantly different by Western Blot, yet high-resolution quantitative confocal imaging revealed that TNFα induces GABA(A)R trafficking to synapses in a dose-dependent manner by 60 min. TNFα-mediated GABA(A)R trafficking represents a novel target for CNS excitotoxicity.


Subject(s)
Cell Membrane/metabolism , Neurons/drug effects , Receptors, GABA-A/metabolism , Spinal Cord/metabolism , Tumor Necrosis Factor-alpha/pharmacology , Animals , Blotting, Western , Cell Membrane/drug effects , Female , Microscopy, Confocal , Neurons/metabolism , Protein Transport/drug effects , Rats , Rats, Long-Evans , Spinal Cord/cytology , Synapses/metabolism
4.
Glia ; 58(11): 1304-19, 2010 Aug 15.
Article in English | MEDLINE | ID: mdl-20607865

ABSTRACT

Wallerian degeneration in the dorsal columns (DC) after spinal cord injury (SCI) is associated with microglial activation and prolonged oligodendrocyte (OL) apoptosis that may contribute to demyelination and dysfunction after SCI. But, there is an increase in OL lineage cells after SCI that may represent a reparative response, and there is evidence for remyelination after SCI. To assess the role of axonal degeneration per se in OL apoptosis and proliferation, we cut the L2-S2 dorsal roots producing massive axonal degeneration and microglial activation in the DC, and found no evidence of OL loss or apoptosis. Rather, the numbers of OL-lineage cells positive for NG2 and APC (CC1) increased, and BrdU studies suggested new OL formation. We then tested contusion SCI (cSCI) that results in comparable degeneration in the DC rostral to the injury, microglial activation, and apoptosis of DC OLs by eight days. NG2+ cell proliferation and oligodendrogenesis was seen as after rhizotomy. The net result of this combination of proliferation and apoptosis was a reduction in DC OLs, confirming earlier studies. Using an antibody to oxidized nucleic acids, we found rapid and prolonged RNA oxidation in OLs rostral to cSCI, but no evidence of oxidative stress in DC OLs after rhizotomy. These results suggest that signals associated with axonal degeneration are sufficient to induce OL proliferation, and that secondary injury processes associated with the central SCI, including oxidative stress, rather than axonal degeneration per se, are responsible for OL apoptosis.


Subject(s)
Apoptosis/physiology , Axons/pathology , Cell Lineage/physiology , Oligodendroglia/pathology , Rhizotomy/methods , Spinal Cord Injuries/pathology , Stem Cells/pathology , Wallerian Degeneration/pathology , Animals , Disease Models, Animal , Female , Oligodendroglia/cytology , Rats , Rats, Long-Evans , Recovery of Function/physiology , Spinal Cord Injuries/surgery , Stem Cells/cytology , Wallerian Degeneration/prevention & control
5.
Crit Care Med ; 37(7): 2160-6, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19487936

ABSTRACT

OBJECTIVE: To use magnetic resonance imaging (MRI) to characterize secondary injury immediately after spinal cord injury (SCI), and to show the effect of hypertonic saline on MRI indices of swelling, edema, and hemorrhage within the cord. DESIGN: A prospective, randomized, placebo-controlled study. SETTING: Research laboratory. SUBJECTS: Twelve adult Long-Evans female rats. INTERVENTIONS: Rats underwent a unilateral 12.5 mm SCI at vertebral level C5. Animals were administered 0.9% NaCl (n = 6) or 5% NaCl (n = 6) at 1.4 mL/kg intravenously every hour starting 30 minutes after SCI. Immediately after SCI, rats were placed in a 4.7T Bruker MRI system and images were obtained continuously for 8 hours using a home-built transmitter/receiver 3 cm Helmholtz coil. Rats were killed 8 hours after SCI. MEASUREMENTS AND MAIN RESULTS: Quantification of cord swelling and volumes of hypointense and hyperintense signal within the lesion were determined from MRI. At 36 minutes after SCI, significant swelling of the spinal cord at the lesion center and extending rostrally and caudally was demonstrated by MRI. Also, at this time point, a hypointense core was identified on T1, PD, and T2 weighted images. Over time this hypointense core reduced in size and in some animals was no longer visible by 8 hours after SCI, although histopathology demonstrated presence of red blood cells. A prominent ring of T2-weighted image hyperintensity, characteristic of edema, surrounded the hypointense core. At the lesion center, this rim of edema occupied the entire unilateral injured cord and in all animals extended to the contralateral side. Administration of HS resulted in increased serum [Na], attenuation of cord swelling, and decreased volume of hypointense core and edema at the last time points. CONCLUSIONS: We were able to use MRI to detect rapid and acute changes in the evolution of tissue pathophysiology, and show potentially beneficial effects of hypertonic saline in acute cervical SCI.


Subject(s)
Edema/prevention & control , Magnetic Resonance Imaging , Myelitis/prevention & control , Saline Solution, Hypertonic/therapeutic use , Spinal Cord Injuries/drug therapy , Spinal Cord Injuries/pathology , Animals , Cervical Vertebrae , Drug Administration Schedule , Edema/etiology , Edema/pathology , Female , Hemorrhage/etiology , Hemorrhage/pathology , Hemorrhage/prevention & control , Myelitis/etiology , Myelitis/pathology , Predictive Value of Tests , Rats , Rats, Long-Evans , Spinal Cord Injuries/complications , Time Factors
6.
J Neurotrauma ; 25(1): 1-18, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18355154

ABSTRACT

Magnetic resonance imaging (MRI) should be a powerful tool for characterization of spinal cord pathology in animal models. We evaluated the utility of medium-field MRI for the longitudinal assessment of progression of spinal cord injury (SCI) in a rat model. Thirteen adult rats were subjected to a 6.25 or 25 g-cm unilateral cervical SCI, and underwent MRI and behavioral tests during a 3-week study period. MRI was also performed post-mortem. Quantification of cord swelling, hypointense and hyperintense signal, and lesion length were the most valuable parameters to determine and were highly correlated to behavioral and histopathological measures. Immediately after injury, MRI showed loss of gray matter-white matter differentiation, presence of scattered hyperintense signal and local hypointense signal, and cord swelling in both groups. At 7 days after injury, the spinal cord in the 25 g-cm group was significantly larger than that of the 6.25 g-cm group (p = 0.02). Contrast enhancement of the lesion was seen at 24 h in the 6.25 g-cm group, and at 24 h and 7 days in the 25 g-cm group. The volume of hypointense signal, representing hemorrhage, throughout the lesion region was significantly larger in the 25 g-cm compared to the 6.25 g-cm group at both 14 and 21 days after SCI (p,

Subject(s)
Magnetic Resonance Imaging/methods , Spinal Cord Injuries/diagnosis , Spinal Cord/pathology , Animals , Cervical Vertebrae , Diagnosis, Differential , Disease Models, Animal , Disease Progression , Edema/diagnosis , Edema/etiology , Edema/physiopathology , Female , Hemorrhage/diagnosis , Hemorrhage/physiopathology , Image Processing, Computer-Assisted , Longitudinal Studies , Nerve Fibers, Myelinated/pathology , Neural Pathways/injuries , Neural Pathways/pathology , Neural Pathways/physiopathology , Predictive Value of Tests , Rats , Severity of Illness Index , Signal Processing, Computer-Assisted , Spinal Cord/physiopathology , Spinal Cord Injuries/complications , Spinal Cord Injuries/physiopathology , Time Factors
7.
J Neuroinflammation ; 4: 28, 2007 Nov 26.
Article in English | MEDLINE | ID: mdl-18039385

ABSTRACT

BACKGROUND: Oligodendrocyte progenitor cells (OPCs) and mature oligodendrocytes are both lost in central nervous system injury and disease. Activated microglia may play a role in OPC and oligodendrocyte loss or replacement, but it is not clear how the responses of OPCs and oligodendrocytes to activated microglia differ. METHODS: OPCs and microglia were isolated from rat cortex. OPCs were induced to differentiate into oligodendrocytes with thyroid hormone in defined medium. For selected experiments, microglia were added to OPC or oligodendrocyte cultures. Lipopolysaccharide was used to activate microglia and microglial activation was confirmed by TNFalpha ELISA. Cell survival was assessed with immunocytochemistry and cell counts. OPC proliferation and oligodendrocyte apoptosis were also assessed. RESULTS: OPCs and oligodendrocytes displayed phenotypes representative of immature and mature oligodendrocytes, respectively. Activated microglia reduced OPC survival, but increased survival and reduced apoptosis of mature oligodendrocytes. Activated microglia also underwent cell death themselves. CONCLUSION: Activated microglia may have divergent effects on OPCs and mature oligodendrocytes, reducing OPC survival and increasing mature oligodendrocyte survival. This may be of importance because activated microglia are present in several disease states where both OPCs and mature oligodendrocytes are also reacting to injury. Activated microglia may simultaneously have deleterious and helpful effects on different cells after central nervous system injury.


Subject(s)
Cell Differentiation/physiology , Microglia/physiology , Oligodendroglia/physiology , Stem Cells/physiology , Analysis of Variance , Animals , Animals, Newborn , Caspase 1/metabolism , Cell Communication , Cell Death/physiology , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Cerebral Cortex/cytology , Enzyme-Linked Immunosorbent Assay/methods , Fibroblast Growth Factors/pharmacology , Gene Expression Regulation/drug effects , Gene Expression Regulation/physiology , Lipopolysaccharides/pharmacology , Platelet-Derived Growth Factor/pharmacology , Rats , Rats, Long-Evans , Stem Cells/drug effects , Thyroid Hormones/pharmacology , Tumor Necrosis Factor-alpha/metabolism
8.
J Neurotrauma ; 23(1): 36-54, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16430371

ABSTRACT

Most experimental studies of spinal cord injury (SCI) in rats damage the thoracic cord, with the consequent functional loss being due to interruption of long tracts connecting the caudal spinal cord to the rostral nervous system. Less work has been done evaluating injury to the cervical cord, even though it is the most common level of human SCI. In addition to the long tracts, the cervical spinal cord contains the sensory and motor neurons responsible for upper extremity function. The purpose of this study was to further develop a rat model of cervical spinal cord contusion injury using a modified NYU/MASCIS weight drop device. Mild (6.25 mm) and moderate (12.5 mm) C5 unilateral injuries were produced. Behavioral recovery was examined using a grooming test, a paw preference test, a walkway test (The Catwalk), and a horizontal ladder test. Histological outcome measures included sparing at the lesion epicenter, sparing throughout the extent of the lesion, quantification of myelin loss rostral and caudal to the lesion, and motor neuron counts. Compared to controls, animals receiving SCI exhibited injury severity-specific deficits in forelimb, locomotor, and hindlimb function persisting for 6-weeks post-SCI. Histological analysis revealed ipsilateral containment of the injury, and differentiation between groups on all measures except motor neuron counts. This model has many advantages: (1) minimal animal care requirements post-SCI, (2) within subject controls, (3) functional loss involves primarily the ipsilateral forelimb, and (4) it is a behavioral and histological model for both gray and white matter damage caused by contusive SCI.


Subject(s)
Efferent Pathways/physiopathology , Motor Neurons/pathology , Nerve Fibers, Myelinated/pathology , Spinal Cord Injuries/physiopathology , Spinal Cord/physiopathology , Wallerian Degeneration/physiopathology , Animals , Cell Death/physiology , Cervical Vertebrae , Disability Evaluation , Disease Models, Animal , Efferent Pathways/pathology , Female , Forelimb/innervation , Forelimb/physiopathology , Functional Laterality/physiology , Gait Disorders, Neurologic/diagnosis , Gait Disorders, Neurologic/physiopathology , Hindlimb/innervation , Hindlimb/physiopathology , Models, Neurological , Neurologic Examination , Predictive Value of Tests , Rats , Rats, Long-Evans , Recovery of Function/physiology , Spinal Cord/pathology , Spinal Cord Injuries/diagnosis , Wallerian Degeneration/pathology
9.
J Neurotrauma ; 22(4): 429-41, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15853461

ABSTRACT

Disruption of bladder function and sexual reflexes are major complications following spinal cord injury (SCI). We examined the use of telemetric monitoring of corpus spongiosum penis (CSP) pressures for assessment of micturition and erectile events following SCI in rats. Pressure catheters were implanted in the bulb of the CSP of seven male Long-Evans hooded rats, subjected to a standardized weight drop SCI (10 g x 12.5 mm) at T10. CSP pressures were analyzed for spontaneously occurring micturition and erectile events, and during ex copula reflex erection tests until 25 days after SCI. Urine volume was determined until 21 days after SCI. Results show initial loss of bladder function after SCI with gradual return of reflex micturition. When compared to baseline (BL), micturition pressure characteristics after SCI included prolonged duration, increased area under the curve (AUC), increased mean pressures, increased number of pressure peaks, and increased peak frequency. At 21 days after SCI, the urine volume per micturition was significantly increased. The number of full erectile events decreased significantly following SCI. Pressure wave analyses demonstrated increased AUC, increased maximum pressures, increased suprasystolic peak duration, increased AUC of the suprasystolic peaks, and increased maximum pressures of the suprasystolic peaks during recovery. The number of partial erectile events decreased significantly following SCI. Ex copula reflex erection testing demonstrated significantly decreased latency. The study demonstrates that telemetric monitoring of CSP pressures in conscious rats is a valuable and reliable method for assessing recovery of autonomic function following SCI.


Subject(s)
Monitoring, Physiologic/methods , Penis/physiopathology , Sexual Dysfunction, Physiological/physiopathology , Spinal Cord Injuries/physiopathology , Telemetry/methods , Urination Disorders/physiopathology , Animals , Consciousness , Copulation/physiology , Disease Models, Animal , Hydrostatic Pressure , Male , Monitoring, Physiologic/instrumentation , Penis/blood supply , Penis/innervation , Rats , Rats, Long-Evans , Recovery of Function/physiology , Reflex/physiology , Sexual Dysfunction, Physiological/etiology , Spinal Cord Injuries/complications , Telemetry/instrumentation , Transducers, Pressure , Urinary Catheterization , Urination/physiology , Urination Disorders/etiology
10.
Nat Commun ; 6: 8581, 2015 Oct 14.
Article in English | MEDLINE | ID: mdl-26466022

ABSTRACT

Data-driven discovery in complex neurological disorders has potential to extract meaningful syndromic knowledge from large, heterogeneous data sets to enhance potential for precision medicine. Here we describe the application of topological data analysis (TDA) for data-driven discovery in preclinical traumatic brain injury (TBI) and spinal cord injury (SCI) data sets mined from the Visualized Syndromic Information and Outcomes for Neurotrauma-SCI (VISION-SCI) repository. Through direct visualization of inter-related histopathological, functional and health outcomes, TDA detected novel patterns across the syndromic network, uncovering interactions between SCI and co-occurring TBI, as well as detrimental drug effects in unpublished multicentre preclinical drug trial data in SCI. TDA also revealed that perioperative hypertension predicted long-term recovery better than any tested drug after thoracic SCI in rats. TDA-based data-driven discovery has great potential application for decision-support for basic research and clinical problems such as outcome assessment, neurocritical care, treatment planning and rapid, precision-diagnosis.


Subject(s)
Brain Injuries , Computational Biology/methods , Disease Models, Animal , Spinal Cord Injuries , Animals , Data Interpretation, Statistical , Rats
11.
Brain Res ; 976(1): 69-74, 2003 Jun 20.
Article in English | MEDLINE | ID: mdl-12763623

ABSTRACT

The cytokine tumor necrosis factor alpha (TNF(alpha)) may act within the neural circuitry of the medullary dorsal vagal complex (DVC) to affect changes in gastric function such as gastric stasis, loss of appetite, nausea, and vomiting. The definitive demonstration that endogenously generated TNF(alpha) is acting within the DVC circuitry to affect these changes has been impeded by the lack of an antagonist for TNF(alpha). The present studies used localized central nervous system microinjections of the TNF-adsorbant construct (TNFR:Fc) to specifically neutralize the ability of endogenously produced TNF(alpha) to activate NST neurons. Our studies reveal that TNFR:Fc suppresses induction of cFos normally evoked by TNF(alpha). These results validate our hypothesis that circulating TNF(alpha) may act directly within the DVC to affect gastric function in a variety of pathophysiological states.


Subject(s)
Immunoglobulin G/pharmacology , Medulla Oblongata/drug effects , Neurons/drug effects , Proto-Oncogene Proteins c-fos/biosynthesis , Recombinant Fusion Proteins/pharmacology , Solitary Nucleus/drug effects , Tumor Necrosis Factor-alpha/physiology , Vagus Nerve/drug effects , Animals , Etanercept , Immunoglobulin G/administration & dosage , Injections, Intraventricular , Male , Medulla Oblongata/metabolism , Microinjections , Neurons/metabolism , Rats , Rats, Long-Evans , Receptors, Tumor Necrosis Factor/administration & dosage , Solitary Nucleus/metabolism , Tumor Necrosis Factor-alpha/administration & dosage , Tumor Necrosis Factor-alpha/pharmacology , Vagus Nerve/metabolism
12.
Exp Neurol ; 261: 97-108, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24999028

ABSTRACT

The goal of the current manuscript was to replicate published data that show intrathecal infusions of Taxol® (paclitaxel), an anti-neoplastic microtubule stabilizing agent, reduce fibrogliotic scarring caused by a dorsal spinal hemisection (DHx) injury and increase functional recovery and growth of serotonergic axons after moderate spinal contusion injury. These experiments were completed as part of an NIH-NINDS contract entitled "Facilities of Research Excellence in Spinal Cord Injury (FORE-SCI) - Replication". Here, data are presented that confirm the anti-scarring effects of Taxol after DHx injury; however, Taxol did not confer neuroprotection or promote serotonergic axon growth nor did it improve functional recovery in a model of moderate spinal contusion injury. Thus, only partial replication was achieved. Possible explanations for disparate results in our studies and published data are discussed.


Subject(s)
Motor Activity/drug effects , Paclitaxel/administration & dosage , Spinal Cord Injuries , Tubulin Modulators/administration & dosage , Amino Acids, Diamino/metabolism , Analysis of Variance , Animals , Antigens/metabolism , Blood-Brain Barrier/drug effects , Blood-Brain Barrier/physiopathology , Collagen Type IV/metabolism , Disease Models, Animal , Female , Fibronectins/metabolism , Gene Expression Regulation/drug effects , Proteoglycans/metabolism , Rats , Rats, Sprague-Dawley , Spinal Cord Injuries/drug therapy , Spinal Cord Injuries/pathology , Spinal Cord Injuries/physiopathology , Time Factors
13.
PLoS One ; 7(3): e33519, 2012.
Article in English | MEDLINE | ID: mdl-22428066

ABSTRACT

Excess glutamate release and associated neurotoxicity contributes to cell death after spinal cord injury (SCI). Indeed, delayed administration of glutamate receptor antagonists after SCI in rodents improves tissue sparing and functional recovery. Despite their therapeutic potential, most glutamate receptor antagonists have detrimental side effects and have largely failed clinical trials. Topiramate is an AMPA-specific, glutamate receptor antagonists that is FDA-approved to treat CNS disorders. In the current study we tested whether topiramate treatment is neuroprotective after cervical contusion injury in rats. We report that topiramate, delivered 15-minutes after SCI, increases tissue sparing and preserves oligodendrocytes and neurons when compared to vehicle treatment. In addition, topiramate is more effective than the AMPA-receptor antagonist, NBQX. To the best of our knowledge, this is the first report documenting a neuroprotective effect of topiramate treatment after spinal cord injury.


Subject(s)
Apoptosis/drug effects , Cervical Vertebrae/injuries , Excitatory Amino Acid Antagonists/pharmacology , Fructose/analogs & derivatives , Neuroprotective Agents/pharmacology , Oligodendroglia/drug effects , Spinal Cord Injuries/drug therapy , Analysis of Variance , Animals , Excitatory Amino Acid Antagonists/therapeutic use , Female , Fructose/pharmacology , Fructose/therapeutic use , Grooming/physiology , Histological Techniques , Movement/physiology , Neuroprotective Agents/therapeutic use , Oligodendroglia/physiology , Quinoxalines/pharmacology , Rats , Rats, Long-Evans , Topiramate
14.
Exp Neurol ; 233(2): 615-22, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21145891

ABSTRACT

These experiments were completed as part of an NIH-NINDS contract entitled "Facilities of Research Excellence - Spinal Cord Injury (FORE-SCI) - Replication". Our goal was to replicate pre-clinical data from Simard et al. (2007) showing that glibenclamide, an FDA approved anti-diabetic drug that targets sulfonylurea receptor 1 (SUR1)-regulated Ca(2+) activated, [ATP](i)-sensitive nonspecific cation channels, attenuates secondary intraspinal hemorrhage and secondary neurodegeneration caused by hemicontusion injury in rat cervical spinal cord. In an initial replication attempt, the Infinite Horizons impactor was used to deliver a standard unilateral contusion injury near the spinal cord midline. Glibenclamide was administered continuously via osmotic pump beginning immediately post-SCI. The ability of glibenclamide to limit intraspinal hemorrhage was analyzed at 6, 12 and 24 h post-injury using a colorimetric assay. Acute recovery (24 h) of forelimb function was also assessed. Analysis of data from these initial studies revealed no difference between glibenclamide and vehicle-treated SCI rats. Later, it was determined that differences in primary trauma affect the efficacy of glibenclamide. Indeed, the magnitude and distribution of primary intraspinal hemorrhage was greater when the impact was directed to the dorsomedial region of the cervical hemicord (as in our initial replication experiment), as compared to the dorsolateral spinal cord (as in the Simard et al. experiment). In three subsequent experiments, injury was directed to the dorsolateral spinal cord. In each case, glibenclamide reduced post-traumatic hemorrhage 24-48 h post-injury. In the third experiment, we also assessed function and found that acute reduction of hemorrhage led to improved functional recovery. Thus, independent replication of the Simard et al. data was achieved. These data illustrate that the injury model and type of trauma can determine the efficacy of pre-clinical pharmacological treatments after SCI.


Subject(s)
Disease Progression , Glyburide/therapeutic use , Hematoma, Epidural, Spinal/pathology , Hematoma, Epidural, Spinal/prevention & control , Spinal Cord Injuries/drug therapy , Spinal Cord Injuries/pathology , Animals , Cervical Vertebrae/pathology , Drug Evaluation, Preclinical/methods , Female , Hematoma, Epidural, Spinal/etiology , Necrosis , Random Allocation , Rats , Rats, Long-Evans , Spinal Cord Injuries/complications
15.
Exp Neurol ; 233(2): 677-85, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22177997

ABSTRACT

These experiments were completed as part of an NIH-NINDS contract entitled "Facilities of Research Excellence-Spinal Cord Injury (FORE-SCI)-Replication". Our goal was to replicate data from a paper published by Dr. Lloyd Guth and colleagues in which combined injections of lipopolysaccharide, indomethacin and pregnenolone (referred to herein as LIP therapy) conferred marked neuroprotection in a pre-clinical model of spinal cord injury (SCI). Specifically, post-injury injection of the combination LIP therapy was found to significantly reduce tissue damage at/nearby the site of injury and significantly improve recovery of locomotor function. In this report, we confirm the primary observations made by Guth et al., however, the effects of LIP treatment were modest. Specifically, LIP treatment improved myelin and axon sparing, axonal sprouting while reducing lesion cavitation. However, spontaneous recovery of locomotion, as assessed using historical (Tarlov scoring) and more current rating scales (i.e., BBB scoring), was not affected by LIP treatment. Instead, more refined parameters of functional recovery (paw placement accuracy during grid walk) revealed a significant effect of treatment. Possible explanations for the neuroprotective effects of LIP therapy are described along with reasons why the magnitude of neuroprotection may have differed between this study and that of Guth and colleagues.


Subject(s)
Indomethacin/administration & dosage , Lipopolysaccharides/administration & dosage , Neuroprotective Agents/administration & dosage , Pregnenolone/administration & dosage , Spinal Cord Injuries/prevention & control , Animals , Drug Evaluation, Preclinical/methods , Drug Therapy, Combination , Female , Pilot Projects , Rats , Rats, Sprague-Dawley , Recovery of Function/drug effects , Recovery of Function/physiology , Spinal Cord Injuries/pathology , Spinal Cord Injuries/physiopathology
16.
Exp Neurol ; 227(1): 159-71, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21040723

ABSTRACT

Transplantation of glial restricted precursor (GRP) cells has been shown to reduce glial scarring after spinal cord injury (SCI) and, in combination with neuronal restricted precursor (NRP) cells or enhanced expression of neurotrophins, to improve recovery of function after SCI. We hypothesized that combining GRP transplants with rolipram and cAMP would improve functional recovery, similar to that seen after combining Schwann cell transplants with increasing cAMP. A short term study, (1) uninjured control, (2) SCI+vehicle, and (3) SCI+cAMP, showed that spinal cord [cAMP] was increased 14days after SCI. We used 51 male rats subjected to a thoracic SCI for a 12-week survival study: (1) SCI+vehicle, (2) SCI+GRP, (3) SCI+cAMP, (4) SCI+GRP+cAMP, and (5) uninjured endpoint age-matched control (AM). Rolipram was administered for 2weeks after SCI. At 9days after SCI, GRP transplantation and injection of dibutyryl-cAMP into the spinal cord were performed. GRP cells survived, differentiated, and formed extensive transplants that were well integrated with host tissue. Presence of GRP cells increased the amount of tissue in the lesion; however, cAMP reduced the graft size. White matter sparing at the lesion epicenter was not affected. Serotonergic input to the lumbosacral spinal cord was not affected by treatment, but the amount of serotonin immediately caudal to the lesion was reduced in the cAMP groups. Using telemetric monitoring of corpus spongiosum penis pressure we show that the cAMP groups regained the same number of micturitions per 24hours when compared to the AM group, however, the frequency of peak pressures was increased in these groups compared to the AM group. In contrast, the GRP groups had similar frequency of peak pressures compared to baseline and the AM group. Animals that received GRP cells regained the same number of erectile events per 24hours compared to baseline and the AM group. Since cAMP reduced the GRP transplant graft, and some modest positive effects were seen that could be attributable to both GRP or cAMP, future research is required to determine how cAMP affects survival, proliferation, and/or function of progenitor cells and how this is related to function. cAMP may not always be a desirable addition to a progenitor cell transplantation strategy after SCI.


Subject(s)
Autonomic Nervous System , Cyclic AMP/therapeutic use , Neuroglia/transplantation , Spinal Cord Injuries/physiopathology , Spinal Cord Injuries/surgery , Stem Cell Transplantation/methods , Analysis of Variance , Animals , Autonomic Nervous System/drug effects , Autonomic Nervous System/pathology , Autonomic Nervous System/physiopathology , Cell Differentiation , Cyclic AMP/metabolism , Disease Models, Animal , Indoles , Locomotion/drug effects , Male , Motor Neurons/drug effects , Motor Neurons/pathology , Nerve Tissue Proteins/metabolism , Neuroglia/drug effects , Penile Erection/drug effects , Rats , Recovery of Function/drug effects , Recovery of Function/physiology , Reflex/drug effects
17.
Am J Physiol Regul Integr Comp Physiol ; 292(3): R1359-67, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17095649

ABSTRACT

We developed a novel technique to simultaneously monitor micturitions and erections in rats by using pressure monitoring within the corpus spongiosum of the penis (CSP). We present data validating this technique and report pressure waveform characteristics of micturition and erectile events during four different behavioral contexts in 10 awake, freely-moving male rats. Telemetric pressure transducers were implanted in the bulb of the CSP. CSP pressure was monitored while the animals were simultaneously recorded on video for determination of presence and volume (n = 7) of micturitions and while the animals underwent behavioral tests for determination of erections. Observed micturitions and CSP pressure waveforms characteristic of micturitions occurred simultaneously (r = 0.98) at a frequency of 32 +/- 4 micturitions per 24 h and with a volume of 0.95 +/- 0.12 ml/urination. Micturition duration recorded by CSP pressure and volume determined by urine weight were highly correlated (r = 0.82). We found that 100% of visually confirmed erectile events occurred simultaneously with CSP pressure waveforms characteristic of erections during ex copula reflex erection tests. During noncontact erection and mating tests more erections were identified by telemetry than by observation alone. Erections during mating tests had a different appearance than those seen in other contexts; they were shorter in duration (P < 0.05) and typically were characterized by a single suprasystolic CSP pressure peak, highlighting the context-specificity of erections. Quality of recordings remained stable in three of four rats we followed for 8 wk. We demonstrate that telemetric recording of CSP pressure provides a quantitative and qualitative assessment of penile erections and micturition in freely behaving rats.


Subject(s)
Copulation/physiology , Penile Erection/physiology , Telemetry/methods , Urination/physiology , Animals , Male , Rats , Rats, Long-Evans , Reproducibility of Results , Telemetry/instrumentation , Transducers, Pressure
18.
Am J Physiol Gastrointest Liver Physiol ; 283(3): G634-9, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12181177

ABSTRACT

Our previous studies suggested that the cytokine tumor necrosis factor-alpha (TNF-alpha) may act within the neural circuitry of the medullary dorsal vagal complex (DVC) to affect changes in gastric function, such as gastric stasis, loss of appetite, nausea, and vomiting. The definitive demonstration that endogenously generated TNF-alpha is capable of affecting gastric function via the DVC circuitry has been impeded by the lack of an antagonist for TNF-alpha. The present studies used localized central nervous system applications of the TNF-adsorbant construct (TNFR:Fc; TNF-receptor linked to the Fc portion of the human immunoglobulin IgG1) to attempt to neutralize the suppressive effects of endogenously produced TNF-alpha. Gastric motility of thiobutabarbital-anesthetized rats was monitored after systemic administration of lipopolysaccharide (LPS) to induce TNF-alpha production. Continuous perfusion of the floor of the fourth ventricle with TNFR:Fc reversed the potent gastroinhibition induced by LPS, i.e., central thyrotropin-releasing hormone-induced increases in motility were not inhibited. This disinhibition of gastric stasis was not seen after intravenous administration of similar doses of TNFR:Fc nor ventricular application of the Fc fragment of human immunoglobulin. These results validate our previous studies that suggest that circulating TNF-alpha may act directly within the DVC to affect gastric function in a variety of pathophysiological states.


Subject(s)
Gastrointestinal Motility/drug effects , Gastrointestinal Motility/physiology , Immunoglobulin G/pharmacology , Lipopolysaccharides/pharmacology , Medulla Oblongata/physiology , Vagus Nerve/physiology , Adsorption , Animals , Etanercept , Fourth Ventricle/metabolism , Humans , Immunoglobulin G/administration & dosage , Injections, Intraventricular , Male , Rats , Rats, Long-Evans , Receptors, Tumor Necrosis Factor/administration & dosage , Thyrotropin-Releasing Hormone/pharmacology , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL